KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab plus chemotherapy vs placebo plus chemotherapy for metastatic TNBC

Cortes J., Cescon D. W. , Rugo H. S. , Im S., Yusof M. M. , Gallardo C., ...More

ANNALS OF ONCOLOGY, vol.32, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 32
  • Publication Date: 2021
  • Doi Number: 10.1016/j.annonc.2021.08.2089
  • Title of Journal : ANNALS OF ONCOLOGY